NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.22
$1.29
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
129,678 shs
Average Volume
21.62 million shs
Market Capitalization
$52.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VTL stock logo

About Vital Therapies Stock (NASDAQ:VTL)

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

VTL Stock News Headlines

Vital Ltd VTL
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Vital Ltd.
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Best Online Therapy For Anxiety Of 2023
5 Best Online Therapy For Teens Of 2023
Occupational Therapy Assistant
Asthma & COPD Therapies Market Report 2023-2033
Vital Limited (VTL.NZ)
Vital Ltd
See More Headlines
Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.54 million
Optionable
Not Optionable
Beta
3.51
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Daniel Vitt
    President, Chief Executive Officer & Director
  • Manfred Gröppel
    Chief Operating Officer
  • Glenn Whaley
    VP-Finance, Chief Financial & Accounting Officer
  • Andreas Muehler
    Chief Medical Officer
  • Hella Kohlhof
    Chief Scientific Officer

VTL Stock Analysis - Frequently Asked Questions

How were Vital Therapies' earnings last quarter?

Vital Therapies, Inc. (NASDAQ:VTL) posted its earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.03.

What other stocks do shareholders of Vital Therapies own?
This page (NASDAQ:VTL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners